Editorial draft — not for publication yet. Methylphenidate content needs review by a qualified UK healthcare professional before publication. For advice about your own prescription, contact your prescriber or pharmacist.

Quick answer

Methylphenidate and lisdexamfetamine are both stimulant medicines used in ADHD care, but they have different active ingredients, formulations, product instructions and side-effect profiles. They are not dose-for-dose substitutes.

Brand-specific product guides for Methylphenidate: Ritalin, Alaradate, Methyphen. These are separate from the generic guide.

Both can be ADHD treatment options, but they are different medicines

NICE recommends methylphenidate or lisdexamfetamine as first-line pharmacological options for adults, and methylphenidate as a first-line option for children aged 5 and over and young people.

The choice depends on response and individual circumstances

NICE describes considering a switch to lisdexamfetamine for children or adults who have not benefited enough after an adequate methylphenidate trial, and considering methylphenidate in certain adults who do not respond sufficiently to lisdexamfetamine.

The clinician considers diagnosis, age, previous treatment, daily routine, health history, formulation, tolerability and licensing. Do not stop one medicine or start another without a prescriber.

Do not compare by tablet strength alone

Milligrams across different active ingredients do not measure equivalent effect. Release type also changes how long a methylphenidate product acts.

If your medicine is not helping or causes problems, discuss the response with the ADHD prescriber. Do not use online conversion tables or someone else’s prescription.

Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.

Frequently asked questions

Is methylphenidate stronger than lisdexamfetamine?

There is no simple milligram comparison. They are different medicines, and an ADHD clinician selects and reviews treatment based on the individual.

Which one does NICE recommend first?

NICE recommends methylphenidate for children aged 5 and over and young people. For adults, it recommends either methylphenidate or lisdexamfetamine as first-line options.

Can I switch between them myself?

No. Do not switch or convert doses without the prescriber responsible for your treatment.

Sources and further reading

This page is based on the following UK sources. Check the leaflet supplied with your own product, as advice can differ between formulations.

Editorial status: Editorial draft — clinical review required before publication. Sources checked on 2 October 2026.

Related information

Read the Methylphenidate overview or continue to another topic: